Ian Hamilton appraises a systematic review and meta-analysis on the association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence.
[read the full story...]
Ian Hamilton reviews a recent longitudinal study from Finland, which explores the psychological stressors predicting increased drinking during the COVID-19 pandemic.
[read the full story...]
Ian Hamilton reviews a recent US study exploring the incidence of treatment for opioid use disorder in people following a non-fatal opiate overdose.
[read the full story...]
Ian Hamilton summarises a systematic review published last week, which explores the role of alcohol use and drinking patterns in socioeconomic inequalities in mortality.
[read the full story...]
Ian Hamilton reflects on the empty shelves in the Supermarket alcohol aisle and wonders how our relationship with alcohol might change during the Coronavirus pandemic.
[read the full story...]
Ian Hamilton shares his thoughts on the new Drug Use series published yesterday in The Lancet: The global drug problem – change but not progression.
[read the full story...]
Ian Hamilton summarises the recently published CIRCLE trial, which looks at the clinical and cost-effectiveness of contingency management for cannabis use in early psychosis.
[read the full story...]
Ian Hamilton looks at a Swedish 42-year follow-up study, which looks at the impact that psychiatric comorbidity can have on premature death in a cohort of patients with substance use disorders.
[read the full story...]
Ian Hamilton explores a recent Finnish study of adolescent tobacco smoking and the risk of psychosis, which found that young people aged 15-16 who smoked more than 10 cigarettes a day were three times more likely to have psychosis by the time they reached age 30.
[read the full story...]
Ian Hamilton and Suzi Gage explain why we know so little about the relationship between cannabis and severe mental illness in women.
[read the full story...]